It is unclear where the U.S. will send the AstraZeneca doses and whether it will send them through COVAX or directly to individual countries. The administration’s decision to commit the doses was first reported by the Associated Press. It comes on the heels of the Biden administration’s announcement that it will send India raw materials and components to manufacture Covishield, a version of the AstraZeneca vaccine produced by the country’s Serum Institute. Those materials were already wrapped up in contracts held by the U.S. But the administration decided over the weekend to divert pending orders of vaccine supplies such as filters to India, and to ship additional drugs, test kits and personal protective equipment. The administration has not yet decided whether to send India AstraZeneca doses directly.
Read more of this story at Slashdot.